Additionally, HIMS has minimal debt levels, with a debt-to-equity ratio below 1%, and holds $300 million in cash, representing a 42% cash-to-assets ratio. These figures underscore HIMS' financial ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

BofA Securities reiterated its Underperform rating on Hims & Hers Health (NYSE:HIMS), keeping its price target steady at $22, ...

Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed Q4 ...

The stock market fell sharply anew on Wednesday, with all major indices ending in the red, as investor sentiment was dampened ...

A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Labcorp Holdings Inc. LH, or Labcorp, is slated to report its first-quarter 2025 results on April 29, before the opening bell ...

HIMS has experienced similar dramatic drops before. During the 2022 inflation surge, the stock fell 87%, and in 2020, it ...

Veterinary telehealth company Dutch is highlighting an overall lack of vet care options for pet owners nationwide.

We will be sharing Q1 2025 hedge fund investor letters in this article. You can also see the hedge fund investor letters for 2024 Q4, 2024 Q3, 2024 Q2 , 2024 Q1, 2023 Q4, 2023 Q3 and 2023 Q2 by ...